CytoDyn, Utek Corp. deal

CYDY acquired UTK subsidiary Advanced Influenza Technologies Inc. for 2 million shares, which values Advanced Influenza at $4.9 million based on CYDY's close of $ 2.45 on July 20, the last trading day...